ProfileGDS5822 / ILMN_2881620
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 69% 73% 58% 72% 61% 56% 66% 75% 69% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 147.269
GSM1276600PDAC Late Ablation Control 27073
GSM1276601PDAC Late Ablation Control 329.658
GSM1276602PDAC Late Ablation 161.172
GSM1276603PDAC Late Ablation 232.861
GSM1276604PDAC Late Ablation 32956
GSM1303940PDAC Late Ablation_anti-CTLA4 135.766
GSM1303941PDAC Late Ablation_anti-CTLA4 2114.875
GSM1303942PDAC Late Ablation_anti-CTLA4 363.669